title: Detection of Trp-P-1 and Trp-P-2, carcinogenic tryptophan pyrolysis products, in dialysis fluid of patients with uremia.
abstract: In order to estimate the exposure levels of mutagenic and carcinogenic heterocyclic amines in humans, we developed a high-performance liquid chromatography method to detect 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1) and 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) in dialysis fluid of patients with uremia. Using this methods, dialysis fluid of 12 patients who had received hemodialysis treatment or continuous ambulatory peritoneal dialysis was examined. Trp-P-1 was detected in dialysate of all uremic patients (727 +/- 282 pmoles, n = 12). In patients who had been treated with continuous ambulatory peritoneal dialysis, the average amount of Trp-P-1 found in whole dialysate (6 l) per day was 710 +/- 203 pmoles (mean +/- S.D., n = 8). Moreover, Trp-P-2 could be detected in 5 out of 12 patients (206 +/- 85 pmoles, n = 5). These results indicate that patients with uremia are actually exposed to carcinogenic tryptophan pyrolysis products. The average exposure level of Trp-P-1 in uremic patients apparently exceeded 710 pmoles (150 ng) per day.
authors.forename: S
authors.initials: S
authors.lastname: Manabe
authors.forename: H
authors.initials: H
authors.lastname: Yanagisawa
authors.forename: S B
authors.initials: SB
authors.lastname: Guo
authors.forename: S
authors.initials: S
authors.lastname: Abe
authors.forename: S
authors.initials: S
authors.lastname: Ishikawa
authors.forename: O
authors.initials: O
authors.lastname: Wada
mesh_terms: D002243:Carbolines / Q000032:analysis* / Q000494:pharmacology; D006801:Humans; D009152:Mutagenicity Tests; D010531:Peritoneal Dialysis, Continuous Ambulatory; D006435:Renal Dialysis; D012486:Salmonella typhimurium / Q000187:drug effects; D014511:Uremia / Q000378:metabolism*
chemical_list: D002243:Carbolines; C019133:3-amino-1-methyl-5H-pyrido(4,3-b)indole; C019132:3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole